News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D
03 Nov 2025
byChristina Lau
In patients with type 2 diabetes (T2D), empagliflozin 25 mg daily offers greater kidney protection than its 10 mg daily dose or dapagliflozin 10 mg daily, a retrospective cohort study in Hong Kong has shown.
03 Nov 2025







